Trinity Biotech (TRIB) Expected to Announce Quarterly Earnings on Wednesday

Trinity Biotech (NASDAQ:TRIBGet Free Report) is expected to post its quarterly earnings results before the market opens on Wednesday, January 29th. Analysts expect Trinity Biotech to post earnings of ($0.54) per share for the quarter.

Trinity Biotech Trading Up 0.9 %

Trinity Biotech stock opened at $0.78 on Monday. The company has a 50-day moving average price of $0.94 and a 200 day moving average price of $1.64. Trinity Biotech has a 12-month low of $0.75 and a 12-month high of $3.55. The stock has a market cap of $5.89 million, a P/E ratio of -0.34 and a beta of 1.01.

About Trinity Biotech

(Get Free Report)

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.

See Also

Earnings History for Trinity Biotech (NASDAQ:TRIB)

Receive News & Ratings for Trinity Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trinity Biotech and related companies with MarketBeat.com's FREE daily email newsletter.